- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01776281
Effects of Kangaroo Mother Care Among Low Birth Weight (LBW) and Preterm Infants (KMC)
Effects of Kangaroo Mother Care Among LBW and Preterm Infants:A Randomized Control Trial in Karachi
- Hypothermia, infections ,and ineffective breastfeeding are some of the commonest causes of deaths among premature and low birth weight LBW infants. Even if the infants are born in facilities, incidences of cold stress are possible due to insufficient resources, space and incompetent practices to manage hypothermia in the immediate postnatal period. Kangaroo Mother Care is a well-known intervention to address the issues related to preterm births, such as hypothermia, infection and prolong hospitalization.Besides significant outcome of KMC interventions for preterm infants, no interventional study has been found in literature in Pakistani context. Looking at the potential benefits of KMC in reducing the related complications of prematurity, the study aims to identify the effectiveness of KMC among preterm and LBW infants born in secondary hospital of Aga khan University hospitals.
Hypothesis I Ha: KMC is effective in reducing the incidences of hypothermia among preterm and LBW infants as compared to the usual care.
Hypothesis II Ha: There is a difference in breastfeeding behavior and breastfeeding outcome among experimental and control group.
Secondary Hypothesis Hypothesis I Ha: There is an association between KMC and frequency of suspected infections during hospitalization.
Hypothesis II Ha: There is a difference in length of stay among experimental group and control group.
Hypothesis III Ha: There is a relationship between KMC and weight gain of infants till four weeks.
Hypothesis IV Ha: There is difference in rate of hypothermia among experimental group and control after discharge from hospital.
Study Overview
Status
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Phase 2
Contacts and Locations
Study Locations
-
-
Sindh
-
Karachi, Sindh, Pakistan, 74500
- Seema Hyderali
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Any preterm neonates (< 37 weeks of gestation by maternal dates)
- Low birth weight infants less than 2500 gm.
Exclusion Criteria:
- Infants with brain hemorrhage, congenital abnormalities.
- Infants needed double phototherapy.
Exclusion of Mother:
Mothers with severe depression, sickness with intensive care requirements. Mother who refused to participate. Mothers who delivered live multiple babies.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: PREVENTION
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: SINGLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
EXPERIMENTAL: Kangaroo Mother Care
Other than routine clinical care per hospital policy.
Infants will receive skin-to-skin contact for minimum one hour daily during hospital stay and at home till one month.
|
|
|
ACTIVE_COMPARATOR: Standard Care
Routine incubator or cot care with breastfeeding support from nurses as per policy.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Breastfeeding outcomes
Time Frame: 30 days
|
Comparison of breastfeeding frequency per day, method of feeding. (partial/ exclusive)in hospital and at home. Breastfeeding behaviour by using preterm Infants breastfeeding behaviour Scale(PIBBS). Follow-up till one months by calling and record keeping of breastfeeding status. |
30 days
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Rate of Infection
Time Frame: 1-2 weeks(During hospital stay)
|
frequency of presume sepsis and need for antibiotics.
|
1-2 weeks(During hospital stay)
|
|
length of stay
Time Frame: 1-2 weeks
|
Total days in hospital during the recruitment period.
|
1-2 weeks
|
|
weight gain
Time Frame: 30 days
|
After discharge observation for weight gain in Follow-up visit.
|
30 days
|
Collaborators and Investigators
Sponsor
Investigators
- Study Director: Rozina Karmaliani, PhD, Aga Kahn University School of Nursing and Midwifery
- Study Director: Zulfiqar Bhutta, AKUH
Study record dates
Study Major Dates
Study Start
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ESTIMATE)
Study Record Updates
Last Update Posted (ESTIMATE)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- SHyderali
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Preterm
-
University of WashingtonRecruitingVery Preterm and Extremely Preterm BirthUnited States
-
Turku University HospitalRecruitingPreterm Infant Development | Preterm Infant HealthJapan, South Korea
-
Ain Shams UniversityCompleted
-
Istanbul University - Cerrahpasa (IUC)Kilis 7 Aralik UniversityCompletedPreterm Labor | Preterm Labor with Preterm Delivery in Third Trimester | Preterm Spontaneous Labor with Preterm DeliveryTurkey
-
Ain Shams UniversityRecruitingPreterm Labor With Preterm DeliveryEgypt
-
PreTeL, IncDuke University; University of RochesterRecruitingPreterm Birth | Threatened Preterm Labor | PreTerm LaborUnited States
-
University Hospital, Strasbourg, FranceRecruitingPreterm Delivery | Threatened Preterm LaborFrance
-
Konya Meram State HospitalRecruitingPregnancy Preterm | Preterm Labor Without DeliveryTurkey
-
Federico II UniversityRecruiting
-
University of OxfordShoklo Malaria Research UnitCompleted
Clinical Trials on Standard Care
-
University of LahoreRecruitingDiabetic Foot UlcerPakistan
-
Neuroscience Trials AustraliaNational Institute for Health Research, United Kingdom; Northern Ireland Chest... and other collaboratorsCompleted
-
Evandro Chagas Institute of Clinical ResearchAlejandro Marcel Hasslocher Moreno, MD MSc PhD student; Andrea Costa, MD PhD; Andrea Silvestre de Sousa, MD PhD and other collaboratorsUnknownChagas Heart DiseaseBrazil
-
Avita MedicalNAMSACompletedVenous Leg UlcersUnited Kingdom, France
-
University of MichiganCompleted
-
The General Hospital of Western Theater CommandRecruitingMucositis | Hematopoietic Stem Cell Transplantation | Radiation-Induced Mucositis | Chemotherapy-Induced MucositisChina
-
Indonesia UniversityCompletedCovid19 | AcupunctureIndonesia
-
University of OklahomaEnrolling by invitationTobacco Cessation | Tobacco Use | Tobacco Smoking | Smoking Cessation Financial Incentives | Socioeconomic Status | Contingency Management | PregnancyUnited States
-
Institut de Cancérologie de LorraineTerminatedBreast CancerFrance
-
brett rasmussenCompleted